Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study - ScienceDirect
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
Chemotherapy Protocol
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) - Annals of Oncology
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Effect of Number of Treatment Cycles of Adjuvant Chemotherapy on Clinical Outcomes | Research To Practice
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
1607-Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense followed by PACLitaxel dose de | eviQ
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet
Recommended antiemetic regimens for HEC and AC-containing regimens... | Download Table
Chemotherapy protocol definition form | Download Scientific Diagram
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052) | Scientific Reports
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial - The Lancet
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
JCM | Free Full-Text | Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
Chemotherapy-Induced Nausea and Vomiting: From Guideline to Clinical Practice - Pharmacy Connection
Breast Cancer Update .com - Web Guide 1 2003
Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
Protocol MCP841 chemotherapy regimen. | Download Table
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
